HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring

NCT07204756 · University of Minnesota

Recruiting

In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study

Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.

Eligibility criteria

Inclusion Criteria: * 18 years or older * Discharged after delivery at University of Minnesota Medical Center * Enrolled into the HOPE-BP Program Exclusion Criteria: * Ongoing antihypertensive medication use at 2 weeks (time of randomization) * Have a medical comorbidity that would not be clinically appropriate to randomize * Patients opted out of clinical research

Study design

Enrollment target: 400 participants

Allocation: randomized

Masking: none

Age groups: adult, older_adult

Timeline

Starts: 2026-01-07

Estimated completion: 2028-01-31

Last updated: 2026-01-14

Interventions

Diagnostic Test: 2-Week Home MonitoringDiagnostic Test: 6-Week Home Monitoring

Primary outcomes

• Diastolic Blood Pressure (Week 6)

Sponsor

University of Minnesota · other

Contacts & investigators

ContactErin Linden · contact · linde491@umn.edu · 612-625-2273

InvestigatorBethany Sabol, MD MAS · principal_investigator, University of Minnesota

All locations (1)

University of MinnesotaRecruiting

Minneapolis, Minnesota, United States

View on ClinicalTrials.gov ↗Find similar trials